Streamlining Aimovig Prior Authorization with CVS Caremark Integration
Klivira automates the prior authorization process for Aimovig with CVS Caremark integration, simplifying a complex workflow that often involves pharmacy benefit management and step therapy protocols.
Managing prior authorizations for specialty medications like Aimovig, particularly through PBMs such as CVS Caremark, presents significant administrative challenges. These complexities arise from specific formulary requirements, step therapy mandates, and the need for precise documentation to secure approval for CGRP receptor antagonists.
Navigating Aimovig Prior Authorization via CVS Caremark
Aimovig (erenumab), a CGRP receptor antagonist for preventive migraine therapy, is typically covered under the pharmacy benefit. This means prior authorization requests for Aimovig with CVS Caremark follow an electronic prior authorization (ePA) workflow, distinct from medical benefit PAs. Klivira integrates directly with payer portals and leverages standards like NCPDP SCRIPT for efficient submission and status tracking.
Common Formulary and Step Therapy Hurdles for Aimovig
CVS Caremark formularies frequently mandate step therapy for CGRP receptor antagonists like Aimovig. Patients often need to demonstrate failed trials of at least two generic oral prophylactic migraine therapies (e.g., topiramate, amitriptyline) before Aimovig is approved. Klivira's platform helps manage the precise documentation and submission of these clinical criteria, ensuring all prior treatment attempts are accurately reported according to PBM guidelines.
Key Documentation for Aimovig PA Submissions
- Patient demographics and comprehensive insurance information.
- Prescribing physician NPI and full contact details.
- Diagnosis codes (ICD-10) for chronic or episodic migraine.
- Detailed documentation of prior trials and failures of at least two generic oral migraine prophylactic agents.
- Patient's migraine history, including frequency, severity, and duration.
- Clinical notes supporting the medical necessity for Aimovig, including contraindications to or intolerance of other therapies.
Specialty Pharmacy Coordination for Erenumab
Once a prior authorization for Aimovig (erenumab) is approved by CVS Caremark, the prescription is typically routed to a CVS Caremark specialty pharmacy for fulfillment. Klivira's platform supports this critical handoff by providing clear approval statuses, facilitating communication between the clinic and the specialty pharmacy, and minimizing delays in medication dispensing to the patient.
Automating the CVS Caremark Aimovig ePA Process with Klivira
Klivira's platform streamlines the end-to-end Aimovig ePA process, from initial submission and real-time status tracking to appeals management. Our robust integration capabilities with PBMs like CVS Caremark reduce manual data entry, accelerate turnaround times, and improve PA approval rates for CGRP receptor antagonist therapies, allowing your team to focus on patient care.
Frequently asked questions
Is Aimovig typically covered under pharmacy or medical benefit by CVS Caremark?
Aimovig (erenumab) is predominantly covered under the pharmacy benefit by CVS Caremark. This means prior authorization requests are processed through their PBM system, often requiring an ePA submission via platforms like Klivira or direct portal interaction, adhering to specific formulary and step therapy protocols.
What is 'step therapy' for Aimovig and how does it affect PA approval?
Step therapy for Aimovig typically requires patients to have tried and failed a specified number of lower-cost, often generic, migraine preventive medications before Aimovig will be approved. Klivira's system helps document these prior trials comprehensively to meet CVS Caremark's formulary requirements and expedite the approval process.
Does Klivira integrate directly with CVS Caremark for Aimovig PAs?
Yes, Klivira integrates with major PBMs, including CVS Caremark, to automate ePA submissions for drugs like Aimovig. This integration facilitates efficient data exchange, real-time status tracking, and significantly reduces the administrative burden on your prior authorization teams, enhancing operational efficiency.
What specific information does CVS Caremark require for an Aimovig PA?
CVS Caremark generally requires patient demographics, prescribing physician details, ICD-10 codes for migraine, and comprehensive documentation of prior treatment failures with other prophylactic migraine therapies. Clinical notes supporting the medical necessity and patient history are also crucial for a successful submission.
Related coverage
Ready to automate this workflow?
See how Klivira automates prior authorizations for your team.
Request a demo